We're glad you asked!
BenchSci's vision is to help scientists bring novel medicine to patients 50% faster by 2025. We do this by empowering scientists with the world's most advanced, easy to use biomedical artificial intelligence software platform, thereby avoiding delays that slow the progress of medicine to clinical trials.
Our technology guides experimental design and accelerates preclinical R&D for over 40,000 scientists, working at more than 4,500 institutions worldwide, including 16 of the top 20 pharmaceutical companies. Organizations that are BenchSci customers see benefits such as quantifiable productivity gains, reduction in spend, and recouped scientist capacity.
- Read the BenchSci story.
- Learn more about the problem we solve: Avoidable Experiment Expenditure.
- Learn more about our applications.
- Read about the impact we have on our customers.